SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
LA JOLLA PHARMACEUTICAL CO
(NQBB:LJPC Last Sale: 7.72 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQBB: (LJPC : $7.72)
$210,101 million Market Cap at Market Close, July 1, 2022
Employs 88.
Biomedics SubIndustry up .00% / Health Industry up .00% Today
6455 Nancy Ridge Drive Research Report Earnings Snapshot - Last 11/12/18
San Diego, CA 92121 Fact Sheet
Phone: (858) 452-6600 Financial Statements
Fax: (858) 452-6893 Peer Comparison
Annual Reports

Deirdre Y. Gillespie, CEO, Gail A. Sloan, SVP, Niv Edward Caviar, CFO
Announced stopped developing experimental lupus treatment, Riquent, February 12, 2009. Developing therapeutics for antibody-mediated autoimmune diseases and inflammation. Were developing Riquent(R) for the treatment of lupus kidney disease. Also developing LJP 1082 for the treatment of antibody-mediated thrombosis, a condition in which patients suffer from recurrent stroke, deep-vein thrombosis, miscarriage and other thrombotic events, and in the early stage of developing small molecules to treat various other autoimmune and inflammatory conditions. Secondary sold 12.25 million shares at $1.40 January 28, 2005. Founded by Andrew Wiseman in 1989.
Historical Charts    Technical Analysis
No Historical Data available for LJPC

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common LJPC $7.72 $7.72 0 .0 $6.81 $7.77 896,465 $6.81 $7.77 27,215,201
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $210,101,352

Split, Dividend and Symbol Change Information
Date Symbol Transaction Dividend Split New Symbol
24-JAN-06 LJPCD Symbol Changed to LJPC
22-DEC-05 LJPC Symbol Changed to LJPCD
21-DEC-05 LJPCD Split 1 for 5

A387
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex